Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5603993 | 1.00 | CYP3A4 (0.58) | CYP3A4TSHRALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL6271165 | 0.92 | CYP3A4 (0.62) | CYP3A4TSHRALDH1A1LPAR3LPAR1 | |
| SCHEMBL6273276 | 0.87 | CYP3A4 (0.62) | CYP3A4TSHRALDH1A1LPAR3LPAR1 | |
| SCHEMBL6273020 | 0.84 | CYP3A4 (0.59) | CYP3A4TSHRALDH1A1LPAR3LPAR1 | |
| SCHEMBL8533131 | 0.84 | CYP3A4 (0.59) | CYP3A4TSHRALDH1A1LPAR3LPAR1 | |
| SCHEMBL5602837 | 0.83 | CYP3A4 (0.61) | CYP3A4TSHRALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL6270783 | 0.83 | CYP3A4 (0.68) | CYP3A4TSHRALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL5600582 | 0.83 | CYP3A4 (0.61) | CYP3A4TSHRALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL6272152 | 0.83 | CYP3A4 (0.83) | CYP3A4TSHRHPGDSMN1; SMN2LPAR3 | |
| SCHEMBL6266753 | 0.81 | CYP3A4 (0.72) | CYP3A4TSHRHPGDSMN1; SMN2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1818361-B1 | Preparing sterile articles from polymers containing a stabiliser based on a poly(oxyalkylene) | OCCIDENTAL CHEM CO (US) | 2013-07-24 | — | — | EP | disclosed |
| EP-1818361-A2 | Preparing sterile articles from polymers containing a stabiliser based on a poly(oxyalkylene) | OCCIDENTAL CHEMICAL CORPORATION (US) | 2007-08-15 | — | — | EP | disclosed |
| EP-1313802-B1 | PREPARING STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE) | OCCIDENTAL CHEM CO (US) | 2007-06-20 | — | — | EP | disclosed |
| EP-1313802-A2 | PREPARING STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE) | OCCIDENTAL CHEMICAL CORPORATION, Occidental Tower (US) | 2003-05-28 | — | — | EP | disclosed |
| US-6451904-B1 | DISCOLORATION INHIBITION OF POLYVINYL CHLORIDE WHEN EXPOSED TO IONIZING RADIATION | OCCIDENTAL CHEMICAL CORPORATION | 2002-09-17 | — | — | US | disclosed |
| US-20020055584-A1 | Preparing sterile articles from polymers containing a stabilizer based on a poly (oxyalkylene) | OCCIDENTAL CHEMICAL CORPORATION | 2002-05-09 | — | — | US | disclosed |
| WO-2002017972-A2 | PREPARING STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE) | OCCIDENTAL CHEMICAL CORPORATION (US) | 2002-03-07 | — | — | WO | disclosed |
| US-6348517-B1 | HALOGEN CONTAINING POLYMERS WITH STABILIZERS FOR STERILE ARTICLES | OXY SERVICES, INC. | 2002-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055584-A1 | Preparing sterile articles from polymers containing a stabilizer based on a poly (oxyalkylene) | SFN, XRCC6, SPOUT1 | CYP3A4 2197/4885TSHR 1248/4885ALDH1A1 3954/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.